U.S. stock futures slip lower; Cook’s firing increases Fed independence worries
NORTHBROOK, Ill. - IDEX Corporation (NYSE:IEX) reported first-quarter 2025 results that surpassed analyst expectations, with adjusted earnings per share of $1.75 beating estimates by $0.08 and revenue of $872 million exceeding the consensus of $810.42 million. The company maintained its full-year organic sales growth and earnings per share guidance ranges despite potential economic headwinds.
IDEX’s first-quarter sales increased 2% YoY but decreased 1% organically. The company reported record orders of $872 million, up 6% overall and 1% organically, marking the fourth consecutive quarter of positive organic order growth. Notably, both the Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP) segments achieved record orders.
Eric Ashleman, IDEX Corporation President and CEO, commented, "Our IDEX teams delivered better than expected revenue and profitability in the first quarter of 2025, with all segments exceeding our expectations. Most encouragingly, all of our segments built backlog, mostly accumulating within HST, fueled by an impressive large clean water project win from the Mott team."
For the second quarter of 2025, IDEX projects earnings per share between $1.95 and $2.05, slightly below the analyst consensus of $2.10. The company’s full-year 2025 EPS guidance of $8.10 to $8.45 aligns with the consensus estimate of $8.11.
Addressing potential economic challenges, IDEX announced an additional $20 million in cost containment actions for 2025 to offset possible tariff-related volume pressure. These measures come on top of the company’s ongoing platform optimization and delayering efforts, which are expected to yield $43 million in impact for 2025.
Ashleman emphasized IDEX’s strong position amid economic uncertainty, citing the company’s critical solutions, long-standing customer relationships, and ability to quickly shift resources to advantaged applications. He also highlighted IDEX’s robust cash generation and balance sheet, which provide flexibility for capital deployment and potential M&A activities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.